Knol AC - Search Results

1

Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones.

Khammari A, Labarrière N, Vignard V, Nguyen JM, Pandolfino MC, Knol AC, Quéreux G, Saiagh S, Brocard A, Jotereau F, Dreno B. Khammari A, et al. Among authors: knol ac. J Invest Dermatol. 2009 Dec;129(12):2835-42. doi: 10.1038/jid.2009.144. Epub 2009 Jun 25. J Invest Dermatol. 2009. PMID: 19554023 Free article. Clinical Trial.

2

Prognostic value of tumor-infiltrating Foxp3+ T-cell subpopulations in metastatic melanoma.

Knol AC, Nguyen JM, Quéreux G, Brocard A, Khammari A, Dréno B. Knol AC, et al. Exp Dermatol. 2011 May;20(5):430-4. doi: 10.1111/j.1600-0625.2011.01260.x. Epub 2011 Mar 16. Exp Dermatol. 2011. PMID: 21410773

3

PD-L1 expression by tumor cell lines: A predictive marker in melanoma.

Knol AC, Nguyen JM, Pandolfino MC, Denis MG, Khammari A, Dréno B. Knol AC, et al. Exp Dermatol. 2018 Jun;27(6):647-655. doi: 10.1111/exd.13526. Exp Dermatol. 2018. PMID: 29505109 Free article.

4

Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.

Knol AC, Lemaître F, Pandolfino MC, Volteau C, Quéreux G, Saiagh S, Khammari A, Viguier M, Dréno B. Knol AC, et al. Exp Dermatol. 2008 May;17(5):436-45. doi: 10.1111/j.1600-0625.2007.00681.x. Epub 2008 Feb 27. Exp Dermatol. 2008. PMID: 18312383

5

Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.

Knol AC, Quéreux G, Brocard A, Ballanger F, Khammari A, Nguyen JM, Dréno B. Knol AC, et al. Exp Dermatol. 2010 Aug;19(8):e95-102. doi: 10.1111/j.1600-0625.2009.00993.x. Exp Dermatol. 2010. PMID: 19845755 Free article.

6

CD8(+) T lymphocytes reactive against Epstein-Barr virus antigens in skin lesions of a patient with Sézary syndrome.

Knol AC, Guilloux Y, Quéreux G, Marques-Briand S, Pandolfino MC, Khammari A, Dreno B. Knol AC, et al. J Am Acad Dermatol. 2005 Nov;53(5):897-900. doi: 10.1016/j.jaad.2005.07.044. J Am Acad Dermatol. 2005. PMID: 16243153

7

Tissue prognostic markers for adoptive immunotherapy in melanoma.

Quereux G, Pandolfino MC, Knol AC, Khammari A, Volteau C, Nguyen JM, Dreno B. Quereux G, et al. Among authors: knol ac. Eur J Dermatol. 2007 Jul-Aug;17(4):295-301. doi: 10.1684/ejd.2007.0203. Epub 2007 Jun 1. Eur J Dermatol. 2007. PMID: 17540635

8

TLR expression in human melanoma cells.

Saint-Jean M, Knol AC, Nguyen JM, Khammari A, Dréno B. Saint-Jean M, et al. Among authors: knol ac. Eur J Dermatol. 2011 Nov-Dec;21(6):899-905. doi: 10.1684/ejd.2011.1526. Eur J Dermatol. 2011. PMID: 21926036

9

Tissue biomarkers in melanoma patients treated with TIL.

Knol AC, Nguyen JM, Pandolfino MC, Quéreux G, Brocard A, Peuvrel L, Saint-Jean M, Saiagh S, Khammari A, Dréno B. Knol AC, et al. PLoS One. 2012;7(12):e48729. doi: 10.1371/journal.pone.0048729. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23284620 Free PMC article.

10

Adoptive TIL transfer in the adjuvant setting for melanoma: long-term patient survival.

Khammari A, Knol AC, Nguyen JM, Bossard C, Denis MG, Pandolfino MC, Quéreux G, Bercegeay S, Dréno B. Khammari A, et al. Among authors: knol ac. J Immunol Res. 2014;2014:186212. doi: 10.1155/2014/186212. Epub 2014 Jan 8. J Immunol Res. 2014. PMID: 24741578 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters